Featured Search - Analysis Shows USPSTF Evidence Backs Mammography at 40
Radiologists from the University of Colorado and the University of Michigan contend that evidence actually shows the benefits of mammography screening women aged 40 to 49 greatly outweigh the possible risks.
Top news from a Feb. 1 featured radiology search on SearchMedica: preventive imaging
United States Preventive Services Task Force Screening Mammography Recommendations: Science IgnoredAmerican Journal of Roentgenology | Feb 1, 2011 (Free abstract. Full text: $10)
Taking a close look at the evidence on which the USPSTF recommended against mammography screening for women aged 40 to 49, radiologists from the University of Colorado and the University of Michigan contend that it actually shows the benefits greatly outweigh the possible risks.
Related Content from Diagnostic Imaging:
The USPSTF Breast Cancer Screening Guidelines: Current and Future Implications
Several months have passed since the publication of the latest US Preventive Services Task Force (USPSTF) breast cancer screening guidelines. The initial, sharp outcry, mainly over the task force’s recommendation against routine screening mammography for women aged 40 to 49 years, has somewhat subsided, but the overall significance of the group’s decision remains undetermined.
Experts Outraged as FDA Panel Says Screening Mammography Should Begin at 50
The U.S. Preventive Services Task Force has issued a recommendation against routine breast cancer screening for women ages 40 to 49 and suggests the screening interval should be changed from every year to every two years beginning at age 50. The new recommendations will result in "many needless deaths," said a joint statement from the American College of Radiology and the Society of Breast Imaging.
Preview: Mammography Rallies on Political Leap Forward
The technological and political evolution of digital mammography will be in evidence on the RSNA exhibit floor.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
